TY - JOUR T1 - Predicting the unpredictable: how dynamic COVID-19 policies and restrictions challenge model forecasts JF - medRxiv DO - 10.1101/2021.09.30.21264273 SP - 2021.09.30.21264273 AU - Farah Houdroge AU - Anna Palmer AU - Dominic Delport AU - Tom Walsh AU - Sherrie L Kelly AU - Samuel W Hainsworth AU - Romesh Abeysuriya AU - Robyn M Stuart AU - Cliff C Kerr AU - Paul Coplan AU - David P Wilson AU - Nick Scott Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/10/01/2021.09.30.21264273.abstract N2 - Introduction To retrospectively assess the accuracy of a mathematical modelling study that projected the rate of COVID-19 diagnoses for 72 locations worldwide in 2021, and to identify predictors of model accuracy.Methods Between June and August 2020, an agent-based model was used to project rates of COVID-19 infection incidence and cases diagnosed as positive from 15 September to 31 October 2020 for 72 geographic settings. Five scenarios were modelled: a baseline scenario where no future changes were made to existing restrictions, and four scenarios representing small or moderate changes in restrictions at two intervals. Post hoc, upper and lower bounds for number of diagnosed Covid-19 cases were compared with actual data collected during the prediction window. A regression analysis with 17 covariates was performed to determine correlates of accurate projections.Results The actual data fell within the lower and upper bounds in 27 settings and out of bounds in 45 settings. The only statistically significant predictor of actual data within the predicted bounds was correct assumptions about future policy changes (OR = 15.04; 95%CI 2.20-208.70; p=0.016).Conclusions For this study, the accuracy of COVID-19 model projections was dependent on whether assumptions about future policies are correct. Frequent changes in restrictions implemented by governments, which the modelling team was not always able to predict, in part explains why the majority of model projections were inaccurate compared with actual outcomes and supports revision of projections when policies are changed as well as the importance of policy experts collaborating on modelling projects.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe original model projections were funded by J&J. No specific funding was received to write and publish this paper.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon request. ER -